| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Workplace Communication > Partnership Conflict - Creating Professional Relationships That Flourish |
|
Useful Advices - Partnership Conflict - Creating Professional Relationships That Flourish
It certainly goes without saying that camaraderie at the top nicely minimizes mistrust and friction. In any case who’s got time to waste on bickering when targets need to be met and you hold the rainmaker status in the firm with all its social obligations. Surely if you set the example and really talk to your co-partners so will your team do the same with each other at all According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product levels? All the management handbooks tell us that top relations drive businesses and you are after all, part of the powerhouse behind business strategy and implementation. Yet how often does strong bonding find itself at partner level? Partners do not always see themselves as part of a team and power struggles are often rife, especially at year end. Personal alliances are ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in orged and some feel very territorial about hard won client accounts and thus arguments become inseparable from important business decisions. Partners will articulate their positions in the face of equally articulate opposition. This is with the backdrop of huge expectations put upon them to master vast amounts of complex materials in a short amount of time and provide effec lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. tive solutions with clear cut answers for demanding clients. Consequently, difficult peer relationships can be a deep source of frustration for many at the top. Is this unrest inevitable with the high stakes involved and strong personalities? We may be tempted by this viewpoint, but this cannot really be an accurate snapshot of the situation that prevails in the upper ech here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe lons. From personal conversations most of my client partners have very good relationships with their peers, but it is clear that there are some inevitable risks attached to this leadership relationship of equals. One partner said that because every action he takes has an important business effect, he feels he is under scrutiny all the time by fellow partners. He is not alwa d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s in the mood to justify every decision he makes and feels his prized autonomy is under threat. A feeling of isolation is also sometimes magnified when there are the politics of dark motives and personal gain that manifest in a competitive and highly driven environment. Creating open handed dealings at partner level is arguably the most organizationally demanding challenge. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Why are some partnerships so susceptible to fall out and yet others are phenomenally successful?
© Shilpa Unalkat - 16/08/2006 When I asked several of my clients about this, I got some interesting feedback. Amongst the usual and predictable answers of open door policies, blue sky days and invitations to fun corporate entertainment jollies, one explanation stood out. Mark easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi an equity partner at a magic circle firm very candidly described how he has carefully cultivated peer relationships at work that are uncomplicated, unemotional and based as a means to an end. The value lies purely on getting what is needed from the other person and giving something back in return. He doesn’t have the time to develop a relationship based on shared hobbies, nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically cquaintance of partner spouse or children. Everything he talks about with his peers is factual and impersonal and he finds this gets things done fast. Management gurus would call this a utilitarian approach and I wondered if there was more behind this convenient and some would say, possibly contrived interaction with work colleagues. When probed further he revealed that the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ re was an underlying lack of mutual trust and he often had strong reservations about the competence and even motives of others at partner level. Interesting how keeping a distance from others in this way builds an invisible wall of self protection. Yet this works for him on a pragmatic level and it is far from a failure situation. People at his firm just get on with things. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi Perhaps this way of being – a little bit of aloofness comes with the territory here. Partner personalities combine a cocktail of strong opinions, powerful intellect and ambition, all certifying ingredients for outstanding leadership performance. This does not lend itself naturally to relationships based on shared feelings and mutual support.
For certain, this sort of one ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a dimensional interaction has its uses, but we need to recognise its limitations. Loyalty, friendship, discretion, mentorship and collegiate style connection is not expected and that in itself may lead to guarding of territories and hostility in some cases.
At the centre of this relationship lies the phenomenon of trust – but is this a complete fantasy, as many firms exist w dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ithout this managerial textbook ideal? Think about the practicalities of developing trust. It takes time, personal interaction (a better method than email) and a willingness to take risks. One false move and hard-won trust has gone. Contrast this with typical partner relationships, which are built on the run, often using impersonal means like blackberrys and frequently sub cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ect to doubt and misperception. On top of that, partner relationships are inevitably political and back-stabbing is not unheard of. By no means do all partners want or have this sort of relationship with their peers. One client said that it was very reassuring that she could call upon her peers to test out ideas, swap honest opinions about the workplace and make time to di tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen cuss things that are not work related. This is the human connection that makes work more fulfilling and rewarding. Having a good laugh with fellow peers featured very highly on her work based values and she was drawn to this particular firm because the staff knew how to relax and were encouraged to express themselves in a less business like way outside of client presence. T t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel hese well chosen personal relationships can benefit the firm immensely and represent what is sometimes called social capital. Firms need to consider their value to business because of what can be achieved through them. Yet they do have their own risks and when things go sour the break-out can be very damaging and could even lead to spectacular business ruin as we have seen ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust y firms disbanding entirely over a partner rift.
There can be no question that peer relationships need a measure of commitment and maintenance which might be a price too high for some. It may be fine to nurture family relationships, but to do the same at work might be way too much like hard work for some people. Perhaps there is an argument that one should decide at the v y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ry outset what sort of relationship needs to be created with individual peers and then stick to it so there is no confusion and expectations are clear cut. Whilst firms may continue to hold the view that any individual is indispensable, yet there is ample evidence around that strong, powerful relationships based on trust between individuals within the firm is the gel that h . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de olds it together and influences the way business is done and therefore ultimately its success. For partnerships to work effectively the individual partners must be able to clearly communicate their ideas, to listen and be willing to disagree. Although it isn’t always easy, learning to appreciate each other’s differences reflects a partner’s ability to manage conflict. When elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip conflict occurs those in leadership positions need to be able to embrace it rather than turn their back and hope it will go away. The successful partner welcomes conflict or at least tolerates it, knowing that if it is well managed it can be the source of change and innovation. Conflict management coaching or training is a useful starting point and can expedite this process tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Annual Report Themes – Ideas for Non-profit Annual Reports Is Perfect Wealth Formula Perfect - Part 2 Business Performance Management-The Critical Piece of the BI Puzzle
|